MedReleaf Australia

Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) together with MedReleaf Australia, announced on Wednesday an enhanced product range of premium medical cannabis oil in Australia. The Canadian medical cannabis giant said the new cannabis oils include a variety of cannabinoid ratios to suit diverse...

In a recent analysis by Canaccord Genuity, the Canadian cannabis giant Aurora Cannabis Inc (NASDAQ:ACB) has seen its investment recommendation upgraded from “hold” to “buy,” reflecting the company’s strategic strides and financial health. This decision reflects a...

In a revealing interview on Benzinga's Cannabis Insider podcast, Miguel Martin, CEO of Aurora Cannabis Inc (NASDAQ:ACB), offered an in-depth look into the company’s remarkable journey and strategic milestones, particularly highlighting their significant achievements in the global medical...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB),and MedReleaf Australia launched IndiMed Tempo 26, a range of new higher THC dried cannabis products for qualified patients under the MedReleaf Concession Scheme. Tempo 26 will add to the portfolio of products available, giving doctors the ability to...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) and MedReleaf Australia launched CraftPlant, a new medical cannabis brand for patients in the Australian market. The CraftPlant brand includes three new products available for doctors to prescribe – Greendae, Navana and HiVolt. All three are THC-...